Tuesday, April 16, 2024

TOPICS

Home Tags Personalized Immunogenicity Assessment tool

Tag: Personalized Immunogenicity Assessment tool

EPIVAX HAS WON a $324,000 grant to develop a web tool that will quickly determine whether Pompe disease patients are at risk for an immune response to enzyme replacement therapy.

EpiVax wins $324K NIH grant to improve Pompe disease treatment

PROVIDENCE — EpiVax Inc. has received a $324,980 Small Business Innovation Research grant to continue development of a web-based test for people at risk...
- Featured Event -

Latest News